259 related articles for article (PubMed ID: 10825483)
1. CRF and urocortin decreased brain stimulation reward in the rat: reversal by a CRF receptor antagonist.
Macey DJ; Koob GF; Markou A
Brain Res; 2000 Jun; 866(1-2):82-91. PubMed ID: 10825483
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats.
Bruijnzeel AW; Zislis G; Wilson C; Gold MS
Neuropsychopharmacology; 2007 Apr; 32(4):955-63. PubMed ID: 16943772
[TBL] [Abstract][Full Text] [Related]
3. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
de Groote L; Peñalva RG; Flachskamm C; Reul JM; Linthorst AC
J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348
[TBL] [Abstract][Full Text] [Related]
4. The behavioural effects of corticotropin-releasing factor-related peptides in rats.
Jones DN; Kortekaas R; Slade PD; Middlemiss DN; Hagan JJ
Psychopharmacology (Berl); 1998 Jul; 138(2):124-32. PubMed ID: 9718281
[TBL] [Abstract][Full Text] [Related]
5. Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2.
Martínez V; Wang L; Rivier JE; Vale W; Taché Y
J Pharmacol Exp Ther; 2002 May; 301(2):611-7. PubMed ID: 11961064
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of lateral septum CRF2 receptors promotes anorexia and stress-like behaviors: functional homology to CRF1 receptors in basolateral amygdala.
Bakshi VP; Newman SM; Smith-Roe S; Jochman KA; Kalin NH
J Neurosci; 2007 Sep; 27(39):10568-77. PubMed ID: 17898228
[TBL] [Abstract][Full Text] [Related]
7. RU 24969, a 5-HT1A/1B agonist, elevates brain stimulation reward thresholds: an effect reversed by GR 127935, a 5-HT1B/1D antagonist.
Harrison AA; Parsons LH; Koob GF; Markou A
Psychopharmacology (Berl); 1999 Jan; 141(3):242-50. PubMed ID: 10027505
[TBL] [Abstract][Full Text] [Related]
8. Sustained AAV-mediated overexpression of CRF in the central amygdala diminishes the depressive-like state associated with nicotine withdrawal.
Qi X; Shan Z; Ji Y; Guerra V; Alexander JC; Ormerod BK; Bruijnzeel AW
Transl Psychiatry; 2014 Apr; 4(4):e385. PubMed ID: 24755994
[TBL] [Abstract][Full Text] [Related]
9. Urocortin shares the memory modulating effects of corticotropin-releasing factor (CRF): mediation by CRF1 receptors.
Zorrilla EP; Schulteis G; Ormsby A; Klaassen A; Ling N; McCarthy JR; Koob GF; De Souza EB
Brain Res; 2002 Oct; 952(2):200-10. PubMed ID: 12376180
[TBL] [Abstract][Full Text] [Related]
10. Interaction between noradrenaline and corticotrophin-releasing factor in the reinstatement of cocaine seeking in the rat.
Brown ZJ; Tribe E; D'souza NA; Erb S
Psychopharmacology (Berl); 2009 Mar; 203(1):121-30. PubMed ID: 18985323
[TBL] [Abstract][Full Text] [Related]
11. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist.
Baram TZ; Chalmers DT; Chen C; Koutsoukos Y; De Souza EB
Brain Res; 1997 Oct; 770(1-2):89-95. PubMed ID: 9372207
[TBL] [Abstract][Full Text] [Related]
12. Feeding microstructure in diet-induced obesity susceptible versus resistant rats: central effects of urocortin 2.
Cottone P; Sabino V; Nagy TR; Coscina DV; Zorrilla EP
J Physiol; 2007 Sep; 583(Pt 2):487-504. PubMed ID: 17627984
[TBL] [Abstract][Full Text] [Related]
13. Human urocortin II, a new CRF-related peptide, displays selective CRF(2)-mediated action on gastric transit in rats.
Million M; Maillot C; Saunders P; Rivier J; Vale W; Taché Y
Am J Physiol Gastrointest Liver Physiol; 2002 Jan; 282(1):G34-40. PubMed ID: 11751155
[TBL] [Abstract][Full Text] [Related]
14. Effects of adolescent alcohol exposure on stress-induced reward deficits, brain CRF, monoamines and glutamate in adult rats.
Boutros N; Der-Avakian A; Kesby JP; Lee S; Markou A; Semenova S
Psychopharmacology (Berl); 2018 Mar; 235(3):737-747. PubMed ID: 29181815
[TBL] [Abstract][Full Text] [Related]
15. Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats.
Turnbull AV; Vale W; Rivier C
Eur J Pharmacol; 1996 May; 303(3):213-6. PubMed ID: 8813571
[TBL] [Abstract][Full Text] [Related]
16. Role of brain arachidonic acid cascade on central CRF1 receptor-mediated activation of sympatho-adrenomedullary outflow in rats.
Yokotani K; Murakami Y; Okada S; Hirata M
Eur J Pharmacol; 2001 May; 419(2-3):183-9. PubMed ID: 11426840
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization.
Huang MM; Overstreet DH; Knapp DJ; Angel R; Wills TA; Navarro M; Rivier J; Vale W; Breese GR
J Pharmacol Exp Ther; 2010 Jan; 332(1):298-307. PubMed ID: 19843974
[TBL] [Abstract][Full Text] [Related]
18. Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor.
Gehlert DR; Shekhar A; Morin SM; Hipskind PA; Zink C; Gackenheimer SL; Shaw J; Fitz SD; Sajdyk TJ
Eur J Pharmacol; 2005 Feb; 509(2-3):145-53. PubMed ID: 15733549
[TBL] [Abstract][Full Text] [Related]
19. Influence of peptide CRF receptor antagonists upon the behavioural effects of human/rat CRF.
Jones DN; Kortekaas R; Hatcher PD; Middlemiss DN; White A; Hagan JJ
Eur J Pharmacol; 1999 Jun; 373(2-3):141-5. PubMed ID: 10414432
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse.
Bruijnzeel AW; Prado M; Isaac S
Biol Psychiatry; 2009 Jul; 66(2):110-7. PubMed ID: 19217073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
